Summary:
Research Innovation is enrolling adults in a clinical research study testing the effectiveness of an investigational hormone replacement therapy for adults with a primary diagnosis of hypothyroidism.
Criteria:- Be between 18 and 75 years old
- Have a primary diagnosis of hypothyroidism
- Have been receiving a continuous thyroid replacement therapy for at least 6 months
- Be classified as euthyroid indicated by at least one documented thyroid stimulating hormone (TSH) value
- Be willing to use an effective contraception method through the study period until 90 days after receiving the last dose of the study drug
- Other criteria will be determined to see if they are eligible. Overall, your participation will last at least 8 visits over a period of about one (1) year.
Qualified Participants May Receive:
Advance hypothyroidism therapy research
Compensation for study related activities